All individual trials at VivaVision Biotech, Inc

An AllTrials project

All individual trials at VivaVision Biotech, Inc

3 out of 3

100.0%

$57,845

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported-late	VivaVision Biotech, Inc	NCT04556838	A Phase 2a, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Safety and Efficacy Activity of 1% and 5% VVN001 Compared to Vehicle in Subjects With Dry Eye Disease	2021-12-01	35
reported	VivaVision Biotech, Inc	NCT05451329	A Phase 2, Double-masked, Randomized, Vehicle-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of VVN539 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension	2022-12-22
reported-late	VivaVision Biotech, Inc	NCT06164743	A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery	2024-05-15	4
ongoing	VivaVision Biotech, Inc	NCT07136805	A Multi-center, Randomized, Single-masked, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of 1.0% VVN461 Ophthalmic Solution in Patients With Non-infectious Anterior Uveitis	2026-12-31

Download this data